Gain insight into research trends and influential papers with Research Intelligence.
doi.org/10.2967/jnumed.119.237016

The Role of68Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience

..., Frederik L. Giesel
58
Volume: 61, Issue: 9, Pages: 1331 - 1336
Published: Feb 14, 2020
Abstract
For oncologic management or radiotherapy planning, reliable staging tools are essential. The recent development of quinoline-based ligands targeting cancer-associated fibroblasts demonstrated promising preclinical and clinical results. The current study aimed to evaluate the role of fibroblast activation protein inhibitor (FAPI) PET/CT as a first clinical analysis for primary malignancies within the lower gastrointestinal tract (LGT)....
Paper Fields
Paper Details
Title
The Role of68Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience
DOI
doi.org/10.2967/jnumed.119.237016
Published Date
Feb 14, 2020
Volume
61
Issue
9
Pages
1331 - 1336
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.